---
title: "Breast Cancer Clinical Trials in California"
description: "Find 1,862 clinical trials for breast cancer near California. Connect with research centers in your area."
url: "https://www.clareohealth.com/clinical-trials/condition/breast-cancer/california"
---

# Breast Cancer Clinical Trials in California

Find 1,862 clinical trials for breast cancer near California. Connect with research centers in your area.

- [All Breast Cancer trials nationwide](https://www.clareohealth.com/clinical-trials/condition/breast-cancer)
- [All trials in California](https://www.clareohealth.com/clinical-trials/location/california)

Showing 1-20 of 1,862 trials

### [A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)](https://www.clareohealth.com/clinical-trials/NCT03255070)

Status: COMPLETED · Phase: PHASE1 · NCT03255070 · Los Angeles, California and 11 others · Sponsor: Ambrx, Inc.

This 2-part, Phase 1, open-label study will determine the recommended Phase 2 dose (RP2D) of ARX788 in subjects with advanced HER2 positive cancers and will assess the safety and a…

### [A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations](https://www.clareohealth.com/clinical-trials/NCT07038369)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · NCT07038369 · Los Angeles, California and 7 others · Sponsor: Atavistik Bio, Inc

This is a Phase 1, open-label study to evaluate the safety and tolerability of ATV-1601 administered orally in adults with AKT1 E17K-mutant, advanced solid tumors and also in HR+/H…

### [Phase II Study in Patients With Operable Breast Cancer](https://www.clareohealth.com/clinical-trials/NCT00518583)

Status: UNKNOWN · Phase: PHASE2 · NCT00518583 · Burbank, California and 8 others · Sponsor: Aptium Oncology Research Network

The study will evaluate the safety and efficacy of the combination PLD, paclitaxel, and trastuzumab in patients with operable breast cancer.

### [Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival](https://www.clareohealth.com/clinical-trials/NCT02364557)

Status: COMPLETED · Phase: PHASE2/PHASE3 · NCT02364557 · Birmingham, Alabama and 161 others · Sponsor: NRG Oncology

This randomized phase II/III trial studies how well standard of care therapy with stereotactic radiosurgery and/or surgery works and compares it to standard of care therapy alone i…

### [Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer](https://www.clareohealth.com/clinical-trials/NCT00404066)

Status: COMPLETED · Phase: PHASE2 · NCT00404066 · San Jose, California and 1 other · Sponsor: George Albert Fisher

This trial combines dose dense chemotherapy with doxorubicin and cyclophosphamide (AC) followed by standard, every 3 week docetaxel and GW572016 (lapatinib) for neoadjuvant treatme…

### [Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy](https://www.clareohealth.com/clinical-trials/NCT03252431)

Status: COMPLETED · Phase: PHASE3 · NCT03252431 · Los Angeles, California · Sponsor: EVIVE Biotechnology

This is a randomized, multi-center, single dose, open-label and Neulasta controlled phase 3 study to evaluate the efficacy and safety of F-627 in women with Stage I - III invasive…

### [A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer](https://www.clareohealth.com/clinical-trials/NCT04916002)

Status: TERMINATED · Phase: PHASE2 · NCT04916002 · Birmingham, Alabama and 23 others · Sponsor: Regeneron Pharmaceuticals

The goal of this study is to learn if giving cemiplimab and vidutolimod together could be effective in treating advanced cancer.

### [Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer](https://www.clareohealth.com/clinical-trials/NCT03939481)

Status: ACTIVE_NOT_RECRUITING · NCT03939481 · Antioch, California and 168 others · Sponsor: SWOG Cancer Research Network

This trial studies treatment effects on development of chemotherapy-induced peripheral neuropathy in patients with cancer.

### [Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer](https://www.clareohealth.com/clinical-trials/NCT05169567)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · NCT05169567 · Phoenix, Arizona and 137 others · Sponsor: Eli Lilly and Company

This study will evaluate the effect of adding abemaciclib to fulvestrant for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HE…

### [A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer](https://www.clareohealth.com/clinical-trials/NCT00077857)

Status: COMPLETED · Phase: PHASE2 · NCT00077857 · Birmingham, Alabama and 93 others · Sponsor: Hoffmann-La Roche

This 2 arm study compared the efficacy and safety of label dose of capecitabine (Xeloda®) to that of a lower dose of Xeloda® plus docetaxel (Taxotere®) in patients with locally adv…

### [Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer](https://www.clareohealth.com/clinical-trials/NCT02673398)

Status: COMPLETED · Phase: PHASE2 · NCT02673398 · Corona, California and 6 others · Sponsor: City of Hope Medical Center

This phase II trial studies the side effects of and how well neratinib works in treating older patients with stage IV HER2-positive breast cancer.

### [Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC](https://www.clareohealth.com/clinical-trials/NCT03838367)

Status: TERMINATED · Phase: PHASE1/PHASE2 · NCT03838367 · San Francisco, California and 1 other · Sponsor: CytoDyn, Inc.

This is a phase Ib/II Study of Leronlimab (PRO 140) combined with Carboplatin in Patients with CCR5+ Metastatic Triple Negative Breast Cancer (mTNBC).

### [Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2](https://www.clareohealth.com/clinical-trials/NCT00544804)

Status: COMPLETED · Phase: PHASE1 · NCT00544804 · San Francisco, California · Sponsor: University of California, San Francisco

RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

### [Combination Chemotherapy in Treating Women With Breast Cancer](https://www.clareohealth.com/clinical-trials/NCT00003519)

Status: COMPLETED · Phase: PHASE3 · NCT00003519 · Birmingham, Alabama and 133 others · Sponsor: Eastern Cooperative Oncology Group

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

### [An Evaluation of a Self-contained Direct Digital Radiography System for Breast Specimen Imaging](https://www.clareohealth.com/clinical-trials/NCT01379092)

Status: UNKNOWN · Phase: NA · NCT01379092 · Newport Beach, California · Sponsor: Levine, Gary M. , M.D.

The objective of this study is to evaluate the image quality and operation of a self-contained direct digital radiography system for breast specimen imaging.

### [A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer](https://www.clareohealth.com/clinical-trials/NCT04075604)

Status: COMPLETED · Phase: PHASE2 · NCT04075604 · Whittier, California and 35 others · Sponsor: Bristol-Myers Squibb

A randomized multi-arm study evaluating the safety and efficacy of palbociclib and anastrozole with or without nivolumab in participants with ER+/HER2- breast cancer

### [A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib](https://www.clareohealth.com/clinical-trials/NCT03744715)

Status: TERMINATED · Phase: PHASE2 · NCT03744715 · Long Beach, California and 4 others · Sponsor: Spectrum Pharmaceuticals, Inc

This is an open-label extension study (Extension Study) designed to allow patients to continue to receive poziotinib treatment who have had previous exposure to poziotinib and/or a…

### [Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations](https://www.clareohealth.com/clinical-trials/NCT05807126)

Status: WITHDRAWN · Phase: PHASE1 · NCT05807126 · Costa Mesa, California and 4 others · Sponsor: National Cancer Institute (NCI)

This phase I/Ib trial studies the side effects and best dose of Hu5F9-G4 (magrolimab) when given in combination with olaparib for the treatment of patients with breast or castrate-…

### [Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer](https://www.clareohealth.com/clinical-trials/NCT00463489)

Status: COMPLETED · Phase: NA · NCT00463489 · Torrance, California and 20 others · Sponsor: Ontario Clinical Oncology Group (OCOG)

The primary objective of this trial is to evaluate the effect of the addition of a 2 year, centrally delivered individualized, telephone-based lifestyle intervention focusing on we…

### [Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC](https://www.clareohealth.com/clinical-trials/NCT02531425)

Status: COMPLETED · Phase: PHASE1 · NCT02531425 · Stanford, California · Sponsor: OncoSec Medical Incorporated

Intratumoral plasmid IL-12 electroporation (IT-pIL12-EP) will be administered to approximately 10 patients with triple negative breast cancer (TNBC) with cutaneous or subcutaneous…

## Breast Cancer Trials in Other Cities

- [New York](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/new-york)
- [Los Angeles](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/los-angeles)
- [Chicago](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/chicago)
- [Houston](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/houston)
- [Phoenix](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/phoenix)
- [Philadelphia](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/philadelphia)

## Other Conditions in California

- [Lung Cancer](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/california)
- [Prostate Cancer](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/california)
- [Colorectal Cancer](https://www.clareohealth.com/clinical-trials/condition/colorectal-cancer/california)
- [Melanoma](https://www.clareohealth.com/clinical-trials/condition/melanoma/california)
- [Leukemia](https://www.clareohealth.com/clinical-trials/condition/leukemia/california)
- [Lymphoma](https://www.clareohealth.com/clinical-trials/condition/lymphoma/california)

Data from [ClinicalTrials.gov](https://clinicaltrials.gov).

---

## Sitemap

This is the Markdown version of https://www.clareohealth.com/clinical-trials/condition/breast-cancer/california.

- [Home](https://www.clareohealth.com/index.md)
- [About](https://www.clareohealth.com/about.md)
- [Pricing](https://www.clareohealth.com/pricing.md)
- [For providers](https://www.clareohealth.com/providers.md)
- [FAQ](https://www.clareohealth.com/faq.md)
- [Blog](https://www.clareohealth.com/blog.md)
- [Clinical trials](https://www.clareohealth.com/clinical-trials.md)
- [Developers](https://www.clareohealth.com/developers.md)
- [Privacy policy](https://www.clareohealth.com/legal/privacy-policy.md)
- [Terms of service](https://www.clareohealth.com/legal/terms-of-service.md)
- [Every page](https://www.clareohealth.com/sitemap.md)
- [About this site, for agents](https://www.clareohealth.com/llms.txt)
